Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Poppitt, S.D
3.3.1 Background Anxiety disorders represent a group of persistent neuropsychiatric conditions affecting approximately 4.05% of the global population, with prevalence rising by over 55% since 1990 (Javaid et al., 2023)
Control experiments were also performed to confirm that compound 102 would not interfere with the dual-luciferase reporter assay system ( Supplementary Figure S10 )
Es un componente fundamental del ciclo del glutatin-ascorbato, sistema que reduce el perxido de hidrgeno [19] txico
10.1073/pnas.1603244113 Proc
US$ 27.99
US$ 21.15
US$ 25.12
